z-logo
Premium
Adjuvant iodine‐131‐labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: Which is the best treatment schedule?
Author(s) -
Tabone Marco,
Vigano Luca,
Laudi Cristiana,
Ferrero Alessandro,
Pellerito Riccardo,
Capussotti Lorenzo
Publication year - 2005
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.20692
Subject(s) - medicine , lipiodol , hepatocellular carcinoma , cirrhosis , adjuvant , gastroenterology , adjuvant therapy , survival rate , iodine , surgery , cancer , materials science , metallurgy

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom